Analysis of lung fibrosis showed no change in modified Ashcroft score, but a trend of decreased α-SMA staining in the nintedanib treated arm (median of 35.5 in the vehicle versus 24.1 in the nintedanib arm, P = 0.24). Here, ACTA1 is linked to pulmonary fibrosis.